Journal of Biomolecular Structure and Dynamics · 2023 · 17 citations · 33 references
Life SciencesBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryEnzymologyChagas DiseaseEnzyme InhibitionHost-parasite InteractionsParasitic Disease PathogenesisParasitic PathogenesisProtozoan Host-parasite InteractionsActive Site ResiduesBenznidazole TherapyMolecular Docking AnalysisNifurtimox TherapyPlant AlkaloidsProtein TargetsTrypanosoma Cruzi InfectionTrypanosomatid-host Interactions
Trypanosoma cruzi is the parasite that causes the chronic malady known as Chagas disease (CD). Only nifurtimox and benznidazole are currently approved to treat CD in acute and chronic phases. To minimize the danger of disease transmission and as a therapy, new compounds that are safer and more effective are required. It has been demonstrated that Amaryllidaceae plants suppress the growth of T. cruzi – the causative agent of CD. However, little research has been done on their potential protein targets in the parasite. In this study, an in-silico approach was used to investigate the interactions of the Amaryllidaceae alkaloids with trans-sialidase, a confirmed protein target of T. cruzi. The nature and efficiency of the main binding modes of the alkaloids were investigated by molecular docking. Trans-sialidase active site residues were bound by the alkaloids with binding energies varying from −8.9 to −6.9 kcal/mol. From the molecular docking investigation, all the alkaloids had strong interactions with the crucial amino acid residues (Glu230, Tyr342, and Asp59) required for trans-sialidase catalysis. Montanine was the most stable compound throughout the molecular dynamics simulation and had a favorable docking binding energy (−8.9 kcal/mol). The binding free energy (MM-GBSA) of the montanine complex was −14.6 kcal/mol. The pharmacokinetic properties investigated demonstrated that all the evaluated compounds exhibit suitable oral administration requirements. Overall, this in silico study suggests that the Amaryllidaceae alkaloids could potentially act as inhibitors of trans-sialidase.Communicated by Ramaswamy H. Sarma
33
CASTp 3.0: computed atlas of surface topography of proteins
Wei Tian, Chang Chen, Xue Lei et al. · Nucleic Acids Research · 2018 · 2.4K citations · Full text
Youjun Xu, Shiwei Wang, Qiwan Hu et al. · Nucleic Acids Research · 2018 · 377 citations · Full text
Chagas disease in European countries: the challenge of a surveillance system
Luca Basile, J.M. Jansà, Yves Carlier et al. · Eurosurveillance · 2011 · 300 citations · Full text
Veterinary Medicine, Infectious Diseases, Maternal Health +17